Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Shares Outstanding (Weighted Average): 2022-2023

Historic Shares Outstanding (Weighted Average) for Therapeutics (LENZ) over the last 2 years, with Dec 2023 value amounting to $8.3 million.

  • Therapeutics' Shares Outstanding (Weighted Average) fell 0.27% to $8.3 million in Q4 2023 from the same period last year, while for Sep 2023 it was $8.3 million, marking a year-over-year decrease of 0.40%. This contributed to the annual value of $27.5 million for FY2024, which is 231.93% up from last year.
  • Latest data reveals that Therapeutics reported Shares Outstanding (Weighted Average) of $8.3 million as of Q4 2023, which was up 0.03% from $8.3 million recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $8.3 million in Q3 2022 and a low of $8.3 million during Q2 2022.
  • For the 2-year period, Therapeutics' Shares Outstanding (Weighted Average) averaged around $8.3 million, with its median value being $8.3 million (2022).
  • The largest annual percentage gain for Therapeutics' Shares Outstanding (Weighted Average) in the last 5 years was 0.26% (2023), contrasted with its biggest fall of 0.40% (2023).
  • Over the past 2 years, Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $8.3 million in 2022, then decreased by 0.27% to $8.3 million in 2023.
  • Its last three reported values are $8.3 million in Q4 2023, $8.3 million for Q3 2023, and $8.3 million during Q2 2023.